Clinical Trial Update: A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating brivaracetam as adjunctive therapy in subjects aged 16 and older with partial seizures with or without secondary generalization has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Seizures with or Without Secondary Generalization

Drugs mentioned

• BRIVARACETAM (brivaracetam)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Partial Seizures With or Without Secondary Generalization, Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2025-07-29